These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12009416)

  • 1. Multi-step analysis as a tool for kinetic parameter estimation and mechanism discrimination in the reaction between tight-binding fasciculin 2 and electric eel acetylcholinesterase.
    Golicnik M; Stojan J
    Biochim Biophys Acta; 2002 May; 1597(1):164-72. PubMed ID: 12009416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fasciculin 2 binds to the peripheral site on acetylcholinesterase and inhibits substrate hydrolysis by slowing a step involving proton transfer during enzyme acylation.
    Eastman J; Wilson EJ; Cerveñansky C; Rosenberry TL
    J Biol Chem; 1995 Aug; 270(34):19694-701. PubMed ID: 7649979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of mouse acetylcholinesterase by fasciculin: crystal structure of the complex and mutagenesis of fasciculin.
    Marchot P; Bourne Y; Prowse CN; Bougis PE; Taylor P
    Toxicon; 1998 Nov; 36(11):1613-22. PubMed ID: 9792178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction kinetics of reversible inhibitors and substrates with acetylcholinesterase and its fasciculin 2 complex.
    Radić Z; Taylor P
    J Biol Chem; 2001 Feb; 276(7):4622-33. PubMed ID: 11036076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate binding to the peripheral site of acetylcholinesterase initiates enzymatic catalysis. Substrate inhibition arises as a secondary effect.
    Szegletes T; Mallender WD; Thomas PJ; Rosenberry TL
    Biochemistry; 1999 Jan; 38(1):122-33. PubMed ID: 9890890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of the neurotoxin fasciculin 2 to the acetylcholinesterase peripheral site drastically reduces the association and dissociation rate constants for N-methylacridinium binding to the active site.
    Rosenberry TL; Rabl CR; Neumann E
    Biochemistry; 1996 Jan; 35(3):685-90. PubMed ID: 8547248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric control of acetylcholinesterase catalysis by fasciculin.
    Radić Z; Quinn DM; Vellom DC; Camp S; Taylor P
    J Biol Chem; 1995 Sep; 270(35):20391-9. PubMed ID: 7657613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The fasciculin-acetylcholinesterase interaction].
    Marchot P
    J Soc Biol; 1999; 193(6):505-8. PubMed ID: 10783708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of kinetic parameters for acetylthiocholine, soman, ketamine and fasciculin towards acetylcholinesterase in liposomes and in solution.
    Puu G; Koch M
    Biochem Pharmacol; 1990 Nov; 40(10):2209-14. PubMed ID: 2244924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of acetylcholinesterase inhibition by fasciculin: a 5-ns molecular dynamics simulation.
    Tai K; Shen T; Henchman RH; Bourne Y; Marchot P; McCammon JA
    J Am Chem Soc; 2002 May; 124(21):6153-61. PubMed ID: 12022850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational transitions in protein-protein association: binding of fasciculin-2 to acetylcholinesterase.
    Bui JM; Radic Z; Taylor P; McCammon JA
    Biophys J; 2006 May; 90(9):3280-7. PubMed ID: 16473897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasciculin inhibition of acetylcholinesterase is prevented by chemical modification of the enzyme at a peripheral site.
    Durán R; Cerveñansky C; Dajas F; Tipton KF
    Biochim Biophys Acta; 1994 Dec; 1201(3):381-8. PubMed ID: 7803468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site of fasciculin interaction with acetylcholinesterase.
    Radić Z; Duran R; Vellom DC; Li Y; Cervenansky C; Taylor P
    J Biol Chem; 1994 Apr; 269(15):11233-9. PubMed ID: 8157652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylcholinesterase inhibition by fasciculin: crystal structure of the complex.
    Bourne Y; Taylor P; Marchot P
    Cell; 1995 Nov; 83(3):503-12. PubMed ID: 8521480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A steric blockade model for inhibition of acetylcholinesterase by peripheral site ligands and substrate.
    Rosenberry TL; Mallender WD; Thomas PJ; Szegletes T
    Chem Biol Interact; 1999 May; 119-120():85-97. PubMed ID: 10421442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and activity of mutants of fasciculin, a peptidic acetylcholinesterase inhibitor from mamba venom.
    Marchot P; Prowse CN; Kanter J; Camp S; Ackermann EJ; Radić Z; Bougis PE; Taylor P
    J Biol Chem; 1997 Feb; 272(6):3502-10. PubMed ID: 9013597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein complex formation by acetylcholinesterase and the neurotoxin fasciculin-2 appears to involve an induced-fit mechanism.
    Bui JM; McCammon JA
    Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15451-6. PubMed ID: 17021015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrostatic influence on the kinetics of ligand binding to acetylcholinesterase. Distinctions between active center ligands and fasciculin.
    Radić Z; Kirchhoff PD; Quinn DM; McCammon JA; Taylor P
    J Biol Chem; 1997 Sep; 272(37):23265-77. PubMed ID: 9287336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The binding sites of inhibitory monoclonal antibodies on acetylcholinesterase. Identification of a novel regulatory site at the putative "back door".
    Simon S; Le Goff A; Frobert Y; Grassi J; Massoulié J
    J Biol Chem; 1999 Sep; 274(39):27740-6. PubMed ID: 10488117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonequilibrium analysis alters the mechanistic interpretation of inhibition of acetylcholinesterase by peripheral site ligands.
    Szegletes T; Mallender WD; Rosenberry TL
    Biochemistry; 1998 Mar; 37(12):4206-16. PubMed ID: 9521743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.